Developmental nephrotoxicity of aristolochic acid in a zebrafish model
-
Add time:07/31/2019 Source:sciencedirect.com
Aristolochic acid (AA) is a component of Aristolochia plant extracts which is used as a treatment for different pathologies and their toxicological effects have not been sufficiently studied. The aim of this study was to evaluate AA-induced nephrotoxicity in zebrafish embryos. After soaking zebrafish embryos in AA, the embryos displayed malformed kidney phenotypes, such as curved, cystic pronephric tubes, pronephric ducts, and cases of atrophic glomeruli. The percentages of embryos with malformed kidney phenotypes increased as the exposure dosages of AA increased. Furthermore, AA-treated embryos exhibited significantly reduced glomerular filtration rates (GFRs) in comparison with mock-control littermates (mock-control: 100 ± 2.24% vs. 10 ppm AA treatment for 3–5 h: 71.48 ± 18.84% ~ 39.41 ± 15.88%), indicating that AA treatment not only caused morphological kidney changes but also induced renal failure. In addition to kidney malformations, AA-treated zebrafish embryos also exhibited deformed hearts, swollen pericardiums, impaired blood circulation and the accumulation(s) of red blood cells. Whole-mount in situ hybridization studies using cmlc2 and wt1b as riboprobes indicated that the kidney is more sensitive than the heart to AA damage. Real-time PCR showed that AA can up-regulate the expression of proinflammatory genes like TNFα, cox2 and mpo. These results support the following conclusions: (1) AA-induced renal failure is mediated by inflammation, which causes circulation dysfunction followed by serious heart malformation; and (2) the kidney is more sensitive than the heart to AA injury.
We also recommend Trading Suppliers and Manufacturers of ARISTOLOCHIC ACID SODIUM SALT (cas 10190-99-5). Pls Click Website Link as below: cas 10190-99-5 suppliers
Prev:Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
Next:Sesquiterpenoids — XVI) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo07/30/2019
- Is aristolochic acid nephropathy a widespread problem in developing countries?07/29/2019
- Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells07/28/2019
- Protective effects of cyclic helix B peptide on aristolochic acid induced acute kidney injury07/27/2019
- Reduced rat plasma lysophosphatidylglycerol or lysophosphatidic acid level as a biomarker of aristolochic acid-induced renal and adipose dysfunctions07/26/2019
- Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP207/25/2019
- Oral exposure to aristolochic acid I induces gastric histological lesions with non-specific renal injury in rat07/24/2019
- Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models07/23/2019
-
Health and Chemical more >


